Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61P - Specific therapeutic activity of chemical compounds or medicinal preparations › A61P 9 - Drugs for disorders of the cardiovascular system
Patents for A61P 9 - Drugs for disorders of the cardiovascular system (159,484)
10/2010
10/21/2010US20100266644 Methods and compositions for administration of iron
10/21/2010US20100266615 D1-1 nucleic acids, polypeptides and related methods
10/21/2010US20100266595 Treatment of insulin-resistant disorders
10/21/2010US20100266583 Inhibition of il-17 production
10/21/2010US20100266581 Compositions and methods for modulating s-nitrosogluthione reductase
10/21/2010US20100266579 Treatment of inflammatory diseases
10/21/2010US20100266575 SOLUBLE FMS-LIKE TYROSINE KINASE-1 (sFLT-1) ANTIBODY AND RELATED COMPOSITION, KIT, METHODS OF USING, AND MATERIALS AND METHOD FOR MAKING
10/21/2010US20100266567 Use of urate oxidase for the treatment or prophylaxis of disorders or indirect sequelae of the heart caused by ischemic or reperfusion events
10/21/2010US20100266556 Method for expanding hematopoietic stem cells using heterocyclic compound
10/21/2010US20100266535 Compounds Having CRTH2 Antagonist Activity
10/21/2010US20100266531 Il-17 binding proteins
10/21/2010US20100266528 Systemic Administration of Colony Stimulating Factors to Treat Amyloid Associated Disorders
10/21/2010US20100266526 Combination therapy for treating hypercholesterolemia
10/21/2010US20100266501 Methods and compositions for organ protection
10/21/2010DE69229688C5 Ophthalmische Zusammensetzungen, die Kombinationen von einem Carboanhydrase-Inhibitor und einem Beta-adrenergischen Antagonist enthalten Containing ophthalmic compositions comprising combinations of a carbonic anhydrase inhibitor and a beta-adrenergic antagonist
10/21/2010CA2758865A1 Herbal compositions and methods for enhancing vital energy and athletic performance
10/21/2010CA2758852A1 Antiepileptic, hypocholesterolemic and neuroprotective compound
10/21/2010CA2758698A1 Vitamin d receptor agonists and uses thereof
10/21/2010CA2758359A1 Fused pyrrolopyridine derivative
10/21/2010CA2758136A1 Use of multi-kinase inhibitors in the treatment of vascular hyperpermeability
10/21/2010CA2758108A1 Process for preparation of endothelial receptor antagonist (bosentan)
10/20/2010EP2241622A2 Human trk receptors and their derivatives
10/20/2010EP2241564A1 3,8-diaminotetrahydroquinoline derivative
10/20/2010EP2241561A1 Neuroprotective, hypocholesterolemic and antiepileptic compound
10/20/2010EP2241555A1 New RAC1 inhibitors as potential pharmacological agents for heart failure treatment
10/20/2010EP2241328A1 Interleukin-1 inhibitors in the treatment of diseases
10/20/2010EP2241315A1 Pharmaceutical composition, use of 2-iminopyrrolidine derivative for production of pharmaceutical composition, and kit for treatment or amelioration of heart diseases
10/20/2010EP2241313A1 Use of flavonoids to increase the bioavailability of hesperetin
10/20/2010EP2241195A1 A method and composition for nutritionally improving glucose control and insulin action
10/20/2010EP2240482A1 Cyclic azaindole-3-carboxamides, their preparation and their use as pharmaceuticals
10/20/2010EP2240480A2 Derivatives of 2-heteroaroyl-imidazol(1,2-a)pyridine,preparation thereof and therapeutic application thereof
10/20/2010EP2240461A1 Substituted furans and use thereof
10/20/2010EP2240448A1 Lactam inhibitors of 11-beta-hydroxysteroid dehydrogenase 1
10/20/2010EP2240028A1 Organic compounds
10/20/2010EP1921065B1 Phenylpyridone derivative
10/20/2010EP1899320B1 Substituted pyrr0lidin-2-0nes , piperidin-2-0nes and isothiazolidine-1, 1-dioxides, their use as kv1 .5 potassium channel blockers and pharmaceutical preparations comprising them
10/20/2010EP1866415B1 A cysteine-containing peptide tag for site-specific conjugation of proteins
10/20/2010EP1747778B1 Anti-fatigue composition
10/20/2010EP1732929B1 Tricyclic benzopyran compound as anti-arrhythmic agents
10/20/2010EP1699759B1 Diphenylazetidinone derivates possessing cholesterol absorption inhibitory activity
10/20/2010EP1689751B1 5,7-diaminopyrazolo[4,3-d]pyrimidines with pde-5 inhibiting activity
10/20/2010EP1360508B1 Prediction of wound healing by urinary nitrate assay
10/20/2010EP1317431B1 Polyarylcarboxamides useful as lipid lowering agents
10/20/2010EP1308438B1 3-substituted urea derivatives and medicinal use thereof
10/20/2010EP1283832B1 Inhibitors of 11-beta-hydroxy steroid dehydrogenase type 1
10/20/2010CN1994155B Healthy oral liquid and preparation method thereof
10/20/2010CN1977890B Chinese medicine composition and its use
10/20/2010CN101868469A Phosphonic acid derivates and their use as P2Y12 receptor antagonists
10/20/2010CN101868443A N-phenyl anthranilic acid derivatives and uses thereof
10/20/2010CN101868235A Compositions and methods for inhibiting the activation of dsRNA-dependent protein kinase and tumor growth inhibition
10/20/2010CN101868156A Citrulline-containing drink
10/20/2010CN101863951A Method for preparing eplerenone
10/20/2010CN101863903A 1,4-dihydrobithiophene [3', 2': 5, 6] bithiapyran [4, 3-c] pyrazol-3-carboxylic acid derivative and application thereof
10/20/2010CN101863900A Novel nitric oxide donating thienopyridine derivative and preparation method and application thereof
10/20/2010CN101863879A Preparation method of alpha crystalline azelnidipine
10/20/2010CN101863878A Polymorphic forms of 3-(4-amino-1-oxo-1,3 dihydro-isoindol-2-yl)-piperidine-2,6-dione
10/20/2010CN101863872A Method for extracting PiPerlonguminine and drug combination comprising same
10/20/2010CN101863871A Total glycosides of Rhodiola rosea, medical application and preparation method thereof
10/20/2010CN101863867A Derivatives of flavonoids compounds and preparation method and application thereof
10/20/2010CN101862501A Medicine bag containing taxus chinensis leaves and taxus chinensis leaf treating and processing devices
10/20/2010CN101862447A Natto kinase composition and preparation method thereof
10/20/2010CN101862446A SOD (Super Oxide Dismutase) grape health care wine
10/20/2010CN101862438A Haemorrhoid paste containing Zingiber corallinum Hance essential oil
10/20/2010CN101862423A Preparation method for coix seed oil microemulsion
10/20/2010CN101862397A Medicinal liquor
10/20/2010CN101862388A Medicament for treating piles and preparation method thereof
10/20/2010CN101862387A Chinese medicament for treating cerebral thrombosis
10/20/2010CN101862375A Compound jellyfish soluble granules for reducing blood pressure and preparation method thereof
10/20/2010CN101862369A Perilla and Rhodiola rosea capsules
10/20/2010CN101862364A Preparation method of traditional Chinese medicinal extract of Chinese angelica and red flower and series preparations thereof
10/20/2010CN101862362A Hydroxypropyl-beta-cyclodextrin inclusion compound of ginseng essential oil, preparation method and application
10/20/2010CN101862340A Application of lactose derivatives Gu-4 used as medicine for treating endotoxin shock
10/20/2010CN101862337A Drug composite containing limaprost and preparation method thereof
10/20/2010CN101862336A Irbesartan-hydrochlorothiazide drug combination liposome solid preparation
10/20/2010CN101862332A Composition for preventing human body injuries by excessive consumption of alcohol and preparation method and application thereof
10/20/2010CN101862329A Amlodipine besylate and atorvastatin calcium medicine compound liposome solid preparation
10/20/2010CN101862328A Valsartan amlodipine capsule medicine compound and preparation method thereof
10/20/2010CN101862327A Application of monascus colors and derivatives in preparing drugs for treating cardiovascular and cerebrovascular diseases
10/20/2010CN101862325A Medicine compound containing candesartan cilexetil
10/20/2010CN101862322A Nebivolol and its pharmaceutically acceptable salts, process for preparation and pharmaceutical compositions of nebivolol
10/20/2010CN101862321A Pharmaceutical composition with functions of hemangiectasis and beta 1 receptor retardation
10/20/2010CN101862318A Combined medicament-combined linolenic acid capable of preventing and fundamentally treating thromboembolic diseases
10/20/2010CN101862304A Uncaria sustained-release tablet and preparation method thereof
10/20/2010CN101862302A Amlodipine besylate liposome tablet
10/20/2010CN101862233A Drug-delivery endovascular stent and method for treating restenosis
10/20/2010CN101862028A Wintergreen extraction method, cigarette comprising same and preparation method thereof
10/20/2010CN101249181B Removing blood stasis Tongmai Chinese medicine compound preparations and method of preparing the same
10/20/2010CN101239092B Kudzuvine flower isoflavonoid extraction, its extracting method, medicinal composition and its use in pharmaceutical
10/20/2010CN101225106B Short peptide suppressing growth of cancer cell and uses thereof
10/20/2010CN101199794B Medicament for treating spermatic funicle vein cirsoid
10/19/2010US7816534 N-[3-(4-chlorophenyl)-2-(3-pyridyl)-1-methylpropyl]-2-(5-trifluoromethyl-2-pyridyloxy)-2-methylpropanamide; obesity; antipsychotic agents; synergistic; cannabinoid receptor antagonists
10/19/2010US7816516 Reacting hydroxyalkyl starch (HAS) with the bioactive agent in a medium that includes water; drug-HAS conjugates for treating tumors, arrythmia, infectious diseases; bioavailability; nontoxic solvents; biodrug activity is not inactivated
10/19/2010US7816511 Screening drugs; prevent gene expression; monitoring cardiovascular disorders
10/19/2010US7816400 Composition comprising natural flavone acacetin, or a pharmaceutically active derivative, analog, salt, glycoside, ester, amide or stereoisomer thereof, effective to inhibit potassium channel function in a patient in need thereof, formulated with a pharmaceutically acceptable vehicle
10/19/2010US7816398 Fatty alcohol drug conjugates
10/19/2010US7816376 Use as excitatory amino acid antagonists for combating neurodegenerative and cerebrovascular diseases, epilepsy, schizophrenia, Alzheimer's, Parkinson's or Huntington's disease, or psychoses; for example, 3-[4-(3,4-methylenedioxybenzyl)piperidino]-N-(2-oxo-2,3-dihydrobenzoxazol-6-yl)propionamide
10/19/2010US7816375 Ligands for monoamine receptors and transporters, and methods of use thereof
10/19/2010US7816363 Inhibitors of histone deacetylase
10/19/2010US7816350 2,6,9-trisubstituted 8-azapurines such as 2-(4-aminocyclohexylamino)-6-benzylamino-9-isopropyl-8-azapurine, used as cyclin-dependent kinase inhibitors, in the treatment of skin disorders, viral infections, cancer, arthritis, lupus, diabetes, multiple sclerosis, restenosis, polycystic kidney disease, gout
10/19/2010US7816347 dual acting compound which acts as a neutral endopeptidase-inhibitor and as an inhibitor of the endogenous endothelin producing system and is selected from daglutril and at least one HMG CoA reductase inhibitor selected from atorvastatin, pravastatin, simvastatin
1 ... 346 347 348 349 350 351 352 353 354 355 356 357 358 359 360 361 362 363 364 365 366 ... 1595